Growth-suppressive activity of raloxifene on liver cancer cells by targeting IL-6/GP130 signaling.
Wang Y, Ma H, Zhao C, Liu T, Yan D, Jou D, Li H, Zhang C, Lü J, Li C, Lin J, Li S, Lin L.
Wang Y, et al. Among authors: li c, li s, li h.
Oncotarget. 2017 May 16;8(20):33683-33693. doi: 10.18632/oncotarget.16898.
Oncotarget. 2017.
PMID: 28430601
Free PMC article.